S&P TSX Capped Composite...

US Dollar vs CAD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

LIXT Lixte Biotechnology Holdings Inc

1.32

0.0499 (3.93%)

After Hours

Last Updated: 16:20:25

Delayed by 15 minutes

Form 3 - Initial statement of beneficial ownership of securities

Lixte Biotechnology (NASDAQ:LIXT)
Historical Stock Chart
From Jan 2025 to Feb 2025

Click Here for more Lixte Biotechnology Charts.

Lixte Biotechnology (NASDAQ:LIXT)
Historical Stock Chart
From Feb 2024 to Feb 2025

Click Here for more Lixte Biotechnology Charts.

Lixte Biotechnology Holdings Inc News

LIXTE Biotechnology Announces Closing of $1.05 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Thursday 13 February 2025 (2 weeks ago) • GlobeNewswire Inc.

LIXTE Biotechnology Announces $1.05 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Tuesday 11 February 2025 (2 weeks ago) • GlobeNewswire Inc.

LIXTE Biotechnology Submits Request for Withdrawal of Form S-1 Registration Statement
Monday 10 February 2025 (2 weeks ago) • GlobeNewswire Inc.

LIXTE Receives U.S. Patent Issue Notification for Immune Oncology
Wednesday 4 September 2024 (6 months ago) • GlobeNewswire Inc.

Form 8-K - Current report
Monday 26 August 2024 (6 months ago) • Edgar (US Regulatory)

First Patient Dosed with LIXTE’s LB-100 in New Clinical Trial to Treat Colorectal Cancer, Collaborating with NKI, Supported by Major Pharma Company
Monday 26 August 2024 (6 months ago) • GlobeNewswire Inc.

Form 8-K - Current report
Friday 23 August 2024 (6 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Monday 19 August 2024 (6 months ago) • Edgar (US Regulatory)

LIXTE Biotechnology Provides Update On Recent Activities and Developments
Monday 19 August 2024 (6 months ago) • GlobeNewswire Inc.

LIXTE Biotechnology Holdings to Present at Two Investor Conferences
Thursday 15 August 2024 (6 months ago) • GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Thursday 8 August 2024 (7 months ago) • Edgar (US Regulatory)

Form 3 - Initial statement of beneficial ownership of securities
Thursday 1 August 2024 (7 months ago) • Edgar (US Regulatory)

More Lixte Biotechnology Holdings Inc News Articles

Accredited Solutions (PK)

Intergrated Cannabis Sol... (PK)

Valiant Eagle (PK)

Asia Broadband (PK)

Lightwave Logic

Kraig Biocraft Laborator... (QB)

NioCorp Developments

AMC Entertainment

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions